{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:51:32Z","timestamp":1790603492041,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T00:00:00Z","timestamp":1725753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ebiom.2024.105359","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T23:16:52Z","timestamp":1727565412000},"page":"105359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Profiling steroid hormone landscape of bladder cancer reveals depletion of intratumoural androgens to castration levels: a cross-sectional study"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0218-5806","authenticated-orcid":false,"given":"Kimmo","family":"Kettunen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3739-2242","authenticated-orcid":false,"given":"Julia","family":"Mathlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarja","family":"Lamminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asta","family":"Laiho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merja R.","family":"H\u00e4kkinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Auriola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Elo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Bostr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Poutanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8849-4604","authenticated-orcid":false,"given":"Pekka","family":"Taimen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ebiom.2024.105359_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105359_bib2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/ijc.23856","article-title":"The effect of smoking on the male excess of bladder cancer: a meta-analysis and geographical analyses","volume":"124","author":"Hemelt","year":"2009","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105359_bib3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.eururo.2015.08.037","article-title":"Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes","volume":"69","author":"Dobruch","year":"2016","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105359_bib4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cncr.23986","article-title":"Sex and racial differences in bladder cancer presentation and mortality in the US","volume":"115","author":"Scosyrev","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105359_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41389-023-00489-9","article-title":"Biological differences underlying sex and gender disparities in bladder cancer: current synopsis and future directions","volume":"12","author":"Doshi","year":"2023","journal-title":"Oncogenesis"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105359_bib6","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41388-019-0964-6","article-title":"Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated G\u03b1i protein\/MAPK\/MMP9 intracellular signaling","volume":"39","author":"Chen","year":"2020","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105359_bib7","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/jnci\/djk113","article-title":"Promotion of bladder cancer development and progression by androgen receptor signals","volume":"99","author":"Miyamoto","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105359_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41419-023-05882-1","article-title":"Androgen dihydrotestosterone promotes bladder cancer cell proliferation and invasion via EPPK1-mediated MAPK\/JUP signalling","volume":"14","author":"Yang","year":"2023","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105359_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-023-03972-4","article-title":"Anti-oncogenic effects of dutasteride, a dual 5-alpha reductase inhibitor and a drug for benign prostate hyperplasia, in bladder cancer","volume":"21","author":"Seok","year":"2023","journal-title":"J\u00a0Transl Med"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105359_bib10","first-page":"276","article-title":"Androgen receptor signaling regulates cell growth and vulnerability to doxorubicin in bladder cancer","volume":"188","author":"Shiota","year":"2012","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105359_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174746","article-title":"Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: a meta-analysis of immunohistochemical studies","volume":"12","author":"Ide","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105359_bib12","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.euf.2020.10.002","article-title":"Switching cancers: a systematic review assessing the role of androgen suppressive therapy in bladder cancer","volume":"7","author":"Kourbanhoussen","year":"2021","journal-title":"Eur Urol Focus"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105359_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.13667","article-title":"Association of 5\u03b1-reductase inhibitor prescription with bladder cancer progression in males in South Korea","volume":"6","author":"An","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105359_bib14","doi-asserted-by":"crossref","first-page":"314.e1","DOI":"10.1016\/j.clgc.2022.10.014","article-title":"Impact of finasteride on survival in bladder cancer: a retrospective multi-institutional database analysis","volume":"21","author":"Garg","year":"2023","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105359_bib15","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.euo.2020.02.010","article-title":"Distribution of molecular subtypes in muscle-invasive bladder cancer is driven by sex-specific differences","volume":"3","author":"de Jong","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105359_bib16","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/apm.13183","article-title":"The inequality of females in bladder cancer","volume":"129","author":"Hyldgaard","year":"2021","journal-title":"APMIS"},{"key":"10.1016\/j.ebiom.2024.105359_bib17","doi-asserted-by":"crossref","first-page":"643870","DOI":"10.3389\/fendo.2021.643870","article-title":"The role of estrogen receptors in urothelial cancer","volume":"12","author":"Goto","year":"2021","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105359_bib18","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1158\/1055-9965.EPI-11-0017","article-title":"Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiology","volume":"20","author":"Davis-Dao","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105359_bib19","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/ijc.28022","article-title":"Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH-AARP diet and health study","volume":"133","author":"Daugherty","year":"2013","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105359_bib20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/ije\/dyz264","article-title":"The impact of hormones and reproductive factors on the risk of bladder cancer in women: results from the Nurses' Health Study and Nurses' Health Study II","volume":"49","author":"Abufaraj","year":"2020","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105359_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/13685538.2020.1808968","article-title":"Testosterone status is not associated with bladder cancer parameters in adult male patients: results of a prospective controlled study","volume":"24","author":"Kafkasli","year":"2021","journal-title":"Aging Male"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105359_bib22","first-page":"1366","article-title":"Serum levels of dehydroepiandrosterone and its sulfate and the risk of developing bladder cancer","volume":"51","author":"Gordon","year":"1991","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105359_bib23","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/13685538.2019.1646238","article-title":"Clinical significance of 5-\u03b1 reductase inhibitor and androgen deprivation therapy in bladder cancer incidence, recurrence, and survival: a meta-analysis and systemic review","volume":"23","author":"Kim","year":"2020","journal-title":"Aging Male"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105359_bib24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.clgc.2021.01.007","article-title":"The use of 5-alpha reductase inhibitors and alpha-1 blockers does not improve clinical outcome in male patients undergoing radical cystectomy for bladder cancer in Quebec, Canada","volume":"19","author":"Wissing","year":"2021","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105359_bib25","first-page":"743","article-title":"Bladder cancer survival of men receiving 5\u03b1-reductase inhibitors","volume":"200","author":"M\u00e4kel\u00e4","year":"2018","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ebiom.2024.105359_bib26","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jpba.2018.11.035","article-title":"Simultaneous analysis by LC\u2013MS\/MS of 22 ketosteroids with hydroxylamine derivatization and underivatized estradiol from human plasma, serum and prostate tissue","volume":"164","author":"H\u00e4kkinen","year":"2019","journal-title":"J\u00a0Pharm Biomed Anal"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105359_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005562","article-title":"ROTS: an R package for reproducibility-optimized statistical testing","volume":"13","author":"Suomi","year":"2017","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105359_bib28","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A\u00a0consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105359_bib29","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/s41467-021-22465-w","article-title":"An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer","volume":"12","author":"Lindskrog","year":"2021","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105359_bib30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1158\/1541-7786.MCR-16-0262","article-title":"Metabolic profiling in formalin-fixed and paraffin-embedded prostate cancer tissues","volume":"15","author":"Cacciatore","year":"2017","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ebiom.2024.105359_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103432","article-title":"Atorvastatin induces adrenal androgen downshift in men with prostate cancer: a post Hoc analysis of a pilot adaptive Randomised clinical trial","volume":"68","author":"Raittinen","year":"2021","journal-title":"eBioMedicine"},{"issue":"13","key":"10.1016\/j.ebiom.2024.105359_bib32","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1158\/1078-0432.CCR-05-0525","article-title":"Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer","volume":"11","author":"Titus","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105359_bib33","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1530\/EJE-15-0380","article-title":"Age-specific population centiles for androgen status in men","volume":"173","author":"Handelsman","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105359_bib34","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1210\/jc.2012-2265","article-title":"Reference ranges and determinants of testosterone, dihydrotestosterone, and estradiol levels measured using liquid chromatography-tandem mass spectrometry in a population-based cohort of older men","volume":"97","author":"Yeap","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105359_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224081","article-title":"Rapid and structure-specific cellular uptake of selected steroids","volume":"14","author":"McManus","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105359_bib36","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.clgc.2015.04.001","article-title":"The estrogen pathway: estrogen receptor-\u03b1, progesterone receptor, and estrogen receptor-\u03b2 expression in radical cystectomy urothelial cell carcinoma specimens","volume":"13","author":"Tan","year":"2015","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105359_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5512-9","article-title":"Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer","volume":"19","author":"Yasui","year":"2019","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105359_bib38","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41585-023-00761-y","article-title":"The androgen receptor in bladder cancer","volume":"20","author":"Chen","year":"2023","journal-title":"Nat Rev Urol"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105359_bib39","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/er.2018-00089","article-title":"Structural and functional biology of aldo-keto reductase steroid-transforming enzymes","volume":"40","author":"Penning","year":"2019","journal-title":"Endocr Rev"},{"issue":"15","key":"10.1016\/j.ebiom.2024.105359_bib40","first-page":"2221","article-title":"High expression of 17\u03b2-hydroxysteroid dehydrogenase type 2 is associated with a better prognosis in urothelial carcinoma of the urinary tract","volume":"7","author":"Wang","year":"2016","journal-title":"J\u00a0Cancer"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105359_bib41","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1158\/0008-5472.CAN-08-0249","article-title":"Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth","volume":"68","author":"Montgomery","year":"2008","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105359_bib42","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.urology.2005.06.079","article-title":"Five-alpha-reductase expression in benign and malignant urothelium: correlation with disease characteristics and outcome","volume":"66","author":"Barocas","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.ebiom.2024.105359_bib43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3233\/BLC-200380","article-title":"5-Reductase inhibitors do not prevent the development and progression of urothelial cancer: in\u00a0vitro evidence","volume":"6","author":"Nagata","year":"2020","journal-title":"Bladder Cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105359_bib44","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ajpath.2017.08.036","article-title":"Antiandrogens reduce intratumoral androgen concentrations and induce androgen receptor expression in castration-resistant prostate cancer xenografts","volume":"188","author":"Knuuttila","year":"2018","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105359_bib45","doi-asserted-by":"crossref","first-page":"435.e23","DOI":"10.1016\/j.urolonc.2020.12.013","article-title":"Characterization of perioperative androgen profiles in men with bladder cancer undergoing radical cystectomy","volume":"39","author":"Smelser","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ebiom.2024.105359_bib46","article-title":"A\u00a0practical guide to handling competing events in etiologic time-to-event studies","volume":"4","author":"Mansournia","year":"2022","journal-title":"Glob Epidemiol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424003955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424003955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T06:05:56Z","timestamp":1729577156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424003955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":46,"alternative-id":["S2352396424003955"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105359","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profiling steroid hormone landscape of bladder cancer reveals depletion of intratumoural androgens to castration levels: a cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105359"}}